Table 1.
Patient demographics
| Characteristic | n (%) |
|---|---|
|
Sex |
|
| Male |
46 (40.4) |
| Female |
68 (59.6) |
|
Age |
|
| Mean +/− SD |
57.7 +/− 11.8 |
| Median |
59.0 |
| Range |
22-88 |
|
Primary tumour type |
|
| Breast |
36 |
| NSCLC |
29 |
| Melanoma |
9 |
| Colorectal |
9 |
| Renal Cell |
6 |
| Oesophageal |
5 |
| Gynaecological |
3 |
| Sarcoma |
2 |
| Prostate |
2 |
| Head and Neck |
2 |
| Thyroid |
1 |
| Hepatocellular |
1 |
| Unknown |
9 |
|
Primary tumour controlled |
|
| Yes |
94 (82.5 |
| No |
20 (17.5) |
|
Extracerebral metastases |
|
| Yes |
66 (57.9) |
| No |
48 (42.1) |
|
ECOG performance status |
|
| 0 |
59 |
| 1 |
47 |
| 2 |
5 |
| 3 |
3 |
|
Recursive partitioning analysis |
|
| I |
26 |
| II |
80 |
| III |
8 |
|
Number of metastases |
|
| 1 |
72 (63.2) |
| 2–3 |
22 (19.3) |
| ≥4 | 20 (17.5) |